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AbsTrACT
Introduction Maternal health services are effective in 
reducing the morbidity and mortality associated with 
pregnancy and childbirth. We conducted a systematic review 
on costs of maternal health services in low- income and 
middle- income countries from the provider’s perspective.
Methods We searched multiple peer- reviewed databases 
(including African Journal Online, CINAHL Plus, EconLit, 
Popline, PubMed, Scopus and Web of Science) and grey 
literature for relevant articles published from year 2000. 
Articles meeting our inclusion criteria were selected with 
quality assessment done using relevant cost- focused criteria 
of the Consolidated Health Economic Evaluation Reporting 
Standards checklist. For comparability, disaggregated costs 
data were inflated to 2019 US$ equivalents. Costs and cost 
drivers were systematically compared. Where heterogeneity 
was observed, narrative synthesis was used to summarise 
findings.
results Twenty- two studies were included, with most 
studies costing vaginal and/or caesarean delivery (11 
studies), antenatal care (ANC) (9) and postabortion care (PAC) 
(8). Postnatal care (PNC) has been least costed (2). Studies 
used different methods for data collection and analysis. 
Quality of peer- reviewed studies was assessed average to 
high while all grey literature studies were assessed as low 
quality. Following inflation, estimated provision cost per 
service varied (ANC (US$7.24–US$31.42); vaginal delivery 
(US$14.32–US$278.22); caesarean delivery (US$72.11–
US$378.940; PAC (US$97.09–US$1299.21); family planning 
(FP) (US$0.82–US$5.27); PNC (US$5.04)). These ranges could 
be explained by intercountry variations, variations in provider 
type (public/private), facility type (primary/secondary) and 
care complexity (simple/complicated). Personnel cost was 
mostly reported as the major driver for provision of ANC, 
skilled birth attendance and FP. Economies of scale in service 
provision were reported.
Conclusion There is a cost savings case for task- shifting 
and encouraging women to use lower level facilities for 
uncomplicated services. Going forward, consensus regarding 
cost component definitions and methodologies for costing 
maternal health services will significantly help to improve 
the usefulness of cost analyses in supporting policymaking 
towards achieving Universal Health Coverage.
InTroduCTIon
Reducing the morbidity and mortality asso-
ciated with pregnancy and childbirth for 
mothers and newborns remains a key priority 
for the health and development agenda in 
the post-2015 era of the Sustainable Devel-
opment Goals (SDGs).1 Following progress 
Key questions
What is already known?
 ► Following a systematic search, we found no review 
in the peer- reviewed literature and the only review 
we found was published in the grey literature and 
included only studies published before year 2000.
 ► The available pre-2000 review is outdated as guid-
ance on several service packages and methods of 
financing healthcare have changed ever since.
What are the new findings?
 ► To the best of our knowledge, this review covering 
17 low- income and middle- income countries pro-
vides the most up- to- date overview of cost of ma-
ternal health service provision in these settings from 
2000 until.
 ► Personnel cost was mostly reported as the major 
cost driver for antenatal care, intrapartum care by 
skilled health personnel and for family planning.
 ► Economies of scale were also observed, with lower 
cost per service observed when more women re-
ceived care.
What do the new findings imply?
 ► The available evidence points to potential cost sav-
ings case for task shifting as a policy for delivery of 
the most critical maternal health services and to the 
need to encourage women to use lower level facili-
ties for non- complicated services in low- income and 
middle- income countries.
 ► Findings from this study provide insights for devel-
oping future global guidelines for costing maternal 
health services in low- income and middle- income 
countries.
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made in reducing global maternal mortality ratio (MMR) 
by 44% during the preceding Millennium Development 
Goal (MDG) era, baseline figures at the start of the SDGs 
era still showed that >300 000 women die annually due to 
pregnancy and childbirth complications, with the deaths 
occurring almost entirely in low- income and middle- 
income countries (LMICs).2 The consensus target for 
the next decade is to reduce MMR to 70 per 100 000 live 
births and newborn mortality ratio to below 12 per 1000 
live births, globally.1
To achieve these targets, the main strategy has been 
centred on ensuring access to quality evidence- based 
maternal health services along the continuum of care.3 
Indeed, the effectiveness of these services, which include 
antenatal care (ANC), skilled birth attendance during 
spontaneous vaginal delivery, Emergency Obstetric Care, 
postnatal care (PNC), postabortion care (PAC) and 
family planning (FP), in reducing these maternal and 
newborn morbidities and mortalities has been reported 
in the literature.4–6 However, in addition to consider-
ations on effectiveness in decision- making to provide 
these services, planners and policy makers need evidence 
on the cost of their provision. Among experts, the prefer-
ence for costing health services is to use robust country- 
specific data collected from representative populations 
for costing health services,7 more so for maternal health 
services.8 Such cost data which will typically include 
component costs for personnel, medicines and supplies, 
laboratory tests, equipment, capital and overheads will 
be useful in complementing the already established 
effectiveness data for cost- effectiveness analyses and will 
better inform priority setting and resource allocation 
for maternal health service provision. A systematic liter-
ature search revealed only one previous review on this 
topic. This was published as a book chapter in year 2000 
and it included papers published mostly in the 1990s.8 
The objective of our review, therefore, was to systemat-
ically assess and summarise recent evidence on costs of 
providing maternal health services in LMICs.
MeTHods
study design
In designing methods used for this review, we lever-
aged best practices for conducting systematic reviews on 
economic evaluations from the Centre for Reviews and 
Dissemination,9 the Task Force on Community Preventive 
Services9 and the Joanna- Brigg’s Institute.10 A protocol- 
guided systematic review was performed following the 
Preferred Reporting Items for Systematic Reviews and 
Meta- Analyses approach (online supplementary table S1 
in file 1).11
search strategy
The protocol used in this review is registered on PROS-
PERO (CRD42018114124) and is published elsewhere.12 
The detailed search strategy used for both peer- review 
and grey literature sources is appended as an online 
supplementary table S2. In summary, from 30 June 2019 
to 30 September 2019, we searched several databases 
including the African Journal Online, CINAHL Plus, 
EconLit, Embase, Popline (until 1 September 2019, when 
the database was retired), PubMed, Scopus and Web of 
Science. As a general principle, in searching the various 
databases, search terms were combined using Boolean 
operators ‘OR’ within categories and ‘AND’ between 
the three categories of terms (words and phrases) that 
captured the interventions of interest (ie, maternal 
health services), their costs and the setting of interest 
(LMICs). For databases where it was not possible to 
specify the setting of interest (African Journal Online, 
Popline and PubMed), we made the call on relevance of 
retrieved articles during the title and abstract screening. 
The combination of these search terms guarantees an 
optimal search strategy for retrieving cost and economic 
studies relevant to maternal health services,13 and was 
developed with support from our institutional librarian. 
Through the entire process of its development, we used 
the checklist by McGowan et al to assess the adequacy of 
our electronic search strategy.14
Following guidance for searching and synthesising grey 
literature in public health,15 we systematically searched 
websites of organisations who report or have interest in 
costing of health services. The websites searched were 
selected based on our experience and that of other 
experts on the subject matter. Specifically, we searched 
websites of Averting Maternal Death and Disability, 
FP2020, Guttmacher Institute, LMIC Ministries of Health, 
Management Sciences for Health, Maternal Health Task 
Force, Population Council, United Nations Fund for 
Population and WHO for relevant reports (including 
costing analyses, white papers, working papers and 
internal documentations) focused on cost of providing 
maternal health services. The grey literature search was 
conducted during the same period that we searched the 
peer- reviewed databases.
In addition to the automated search for peer- reviewed 
and grey literature, we also manually searched for other 
potentially relevant articles by reviewing the reference 
lists of retrieved articles. If a study was found in the grey 
literature, which was later published in the peer- reviewed 
literature, the peer- reviewed version was selected for the 
purposes of our review.
For both peer- review and grey literature, we limited 
the search to studies published between January 2000 
and September 2019 (the end date for our search), and 
written in English and French languages, as these were 
the languages comprehensible by the review team. The 
search was conducted independently by three authors 
(AB- T, FIA and OB- T), with search results compared 
for completeness. After duplicates were removed, two 
authors (AB- T and FIA) independently screened titles and 
abstracts of the retrieved records for relevance and eligi-
bility, with the senior author (CAA) serving as arbitrator 
in case of discrepancies. If titles or abstracts were deemed 
relevant, full text were reviewed by AB- T and FIA. Full 
 on July 8, 2020 by guest. P
rotected by copyright.
http://gh.bm
j.com
/
B
M
J G
lob H
ealth: first published as 10.1136/bm
jgh-2020-002371 on 21 June 2020. D
ow
nloaded from
 
Banke- Thomas A, et al. BMJ Global Health 2020;5:e002371. doi:10.1136/bmjgh-2020-002371 3
BMJ Global Health
Figure 1 Preferred Reporting Items for Systematic Reviews 
and Meta- Analyses flow chart.
texts were subsequently stored in shared folders within 
an automated reference manager, Mendeley Desktop 
V.1.19.4 (Elsevier, Amsterdam, The Netherlands).
Inclusion and exclusion criteria
To be included, articles had to present cost data specific 
for any of the maternal health services collected from 
one or multiple LMIC(s) (as defined by the World 
Bank),16 from the provider’s perspective. Such cost data 
are typically reported in full (cost minimisation, cost- 
effectiveness, cost- utility and cost- benefit analyses) and 
partial (cost analysis, cost- description studies and cost- 
outcome studies) economic evaluation studies.17 As such, 
full or partial economic evaluations on cost of providing 
maternal health services in LMICs published between 
January 2000 and September 2019, with retrievable full 
texts were included for review.
However, articles were excluded if costing was done 
based on models/projections or if they presented costs 
that could not be split by individual service (ANC, skilled 
birth attendance, PNC, PAC, FP). We also excluded 
commentaries and editorials. In addition, articles 
that presented cost categories (eg, US$0–US$500), as 
opposed to actual costs as well as studies published year 
2000 onwards using cost data preceding year 2000 were 
excluded. This decision was made in consideration of the 
marked difference in health financing approach after 
year 2000.18 19 Finally, we excluded studies that focused 
on specialist services such as ANC for HIV- positive 
mothers as they would typically include additional tests 
and medicines targeted at prevention of mother- to- child 
transmission.
data extraction
Guidance on approach and content for data extraction 
were sought from previous reviews and expert opinion.8 20 
In our review, we used a predeveloped Microsoft Excel 
(Microsoft, Redmond, Washington, USA) sheet to 
extract data. We extracted data on country of study, scale 
of study, site of study, country of organisation conducting 
study, study participants, perspective of costing, study 
design, costing of maternal health services costed, costing 
method used, time frame, facility type, facility ownership, 
number of facilities, component of cost, year of costs 
data, currency, stated exchange rate used for analysis and 
discount rate) as well as findings reported including total 
service cost per client visit and/or other summary meas-
ures of cost such as median and mean.
When specific data were missing from retrieved articles 
or not publicly available, we made attempts to contact 
the study authors via portals such as ResearchGate and 
LinkedIn. Data extraction was conducted independently 
by two coauthors (AB- T and FIA) and then checked for 
accuracy by two others (IOA and OB- T).
Quality assessment of included studies
The 24- item Consolidated Health Economic Evalua-
tion Reporting Standards (CHEERS) checklist has been 
widely used for assessing the quality of reporting of full 
economic evaluations.21 However, as partial economic 
evaluation studies which capture purely cost data were 
included in this review,17 only the cost- focused criteria in 
the CHEERS checklist were applied in this review. This 
choice was based on quality assessments used in similar 
reviews.22–24
Details of the quality criteria assessed have been 
published elsewhere.12 In summary, for each item, a 
score of 1 was awarded if the criterion is fully met; 0.5, 
if partially met; 0, if not met or if only minimal informa-
tion was provided and NA if not applicable. The total 
score achieved across all eight criteria was subsequently 
summed- up and converted to percentages. As has been 
done in other similar reviews,22–24 studies with 75% or 
more criteria fully met were classified as high quality, 
50%–74% as average quality and below 50% as poor 
quality. Each included study was independently assessed 
by two coauthors (AB- T and FIA).
data analysis and synthesis
Using a subgroup analysis, the different cost components 
associated with each service were identified. Articles that 
included only lump total service costs or those that had 
total service costs which could not be disaggregated into 
service cost components were analysed separately.
For those that presented disaggregated cost of service 
provision (cost per service), where possible, opportunity 
costs, if included, were excluded before totalling the 
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Figure 2 Geographical distribution of included studies. ANC, antenatal care; FP, family planning; LMICs, low- income and 
middle- income countries; PAC, postabortion care; PNC, postnatal care; SBA, skilled birth attendant.
direct financial cost of each service, which was the focus 
of our analysis. We also excluded cost that were deemed 
additional to actual service delivery such as training, 
scholarship funds for health workers and transport funds 
for ambulatory services from our analysis. For these, lever-
aging guidance on adjustments for inflation and currency 
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changes for health economic studies,25 we used a mixed 
approach to inflate disaggregated component costs, with 
a general agreement that medicines, supplies and equip-
ment are tradable costs while personnel, capital and over-
heads are non- tradable. We inflated component costs to 
2019 values using the Gross Domestic Product (GDP) 
implicit price deflator for the year of costing as stated in 
the study and our selected base year (2019) using esti-
mates derived from the World Economic Outlook data-
base,26 presenting these component costs in US$.25 Based 
on these adjusted US$ equivalents, total cost per service 
estimates were recalculated by summing up the compo-
nent costs. We then compared our derived adjusted costs 
across studies, across facility type (health centre/clinic/
hospital), provider type (public/mission/private) and 
complexity of care (simple/complicated). In addition, 
we analysed component costs of service provision, high-
lighted major cost drivers and attempted to explain any 
observed patterns, taking cognizance of any methodolog-
ical differences.
Finally, where we found that it was not possible to 
disaggregate costs, we captured their stated total cost per 
service estimates and explored any emerging patterns 
within services, as part of a broader narrative synthesis.10
Patient and public involvement
Patients and the public were not involved in the design of 
this systemic review.
resulTs
After duplicates were removed, 24 452 articles were 
screened by title and abstract for inclusion in the full- 
text review. Subsequently, the full- text of 116 articles 
were read, of which 18 articles met the inclusion criteria. 
Four additional articles were identified by snowballing 
through the bibliography of the selected articles. Thus, 
22 studies were included in our narrative review of 
which 15 provided disaggregated component cost for 
our analysis (figure 1). Nineteen of the included studies 
were retrieved from peer- review literature,27–45 while the 
remaining three were sourced from grey literature.46–48
distribution and quality assessment of included studies
Thirteen studies were conducted in low- income coun-
tries (LICs) including four in Rwanda,35 41 45 46 two each 
in Tanzania32 36 and Uganda29 34 and one each in Burkina 
Faso,43 Democratic Republic of the Congo,27 Ethiopia,33 
Haiti48 and Somalia.47 Five studies were conducted 
in lower- middle- income countries, with one each 
conducted in Bangladesh,37 Ghana,39 Nigeria,28 Paki-
stan42 and Zambia.30 Four studies were done in upper- 
middle- income countries (UMICs) including Brazil,40 
Colombia,31 Peru38 and South Africa (figure 2).44
Eleven studies were assessed as high quality,31 34 35 37–39 41–45 
eight were average quality27–30 32 33 36 40 and three were low 
quality.46–48 The criteria warranting the least scores were 
those related to detailing a breakdown of costs incurred 
for providing the service and incorporating indirect costs 
in the analysis (online supplementary table S3 in file 1).
In terms of the maternal health services that have 
been costed, 11 studies reported costs of vaginal and/
or caesarean delivery.27 29 32 36 37 39 40 42 45–47 Nine studies 
costed provision of ANC.29 32 36–39 41 47 48 Eight studies 
costed provision of some form of care for abortion and/
or its complication.28 30 33–35 43 44 Four studies costed family 
planning29 36 37 48 and two studies costed PNC provision37 47 
(online supplementary table S4 in file 1). Eleven studies 
were done at a subnational scale.28 29 32 33 37 39–41 46–48 Four 
studies were each conducted in multiple facilities within 
one district27 36 38 42 and within several representative facil-
ities at a national scale,31 34 35 while another four studies 
costed services within a single facility.30 43–45
Methods used in collecting and analysing cost data
Eight studies used a cross- sectional study design using 
primary data.28 29 37 39–43 Two studies each used a retro-
spective cross- sectional study32 38 or a mixed methods 
design,36 45 and one was a cost- effectiveness analysis.44 
Four studies reported using the Post- Abortion Care 
Costing Methodology (PACCM).31 33–35 Five studies did 
not specifically state the study design used.27 30 46–48 For 
data collection, cost data were collected either with a 
questionnaire as part of a survey,37 38 40 41 with a bespoke 
data collection tool based on the Savings tool in the 
WHO’s Mother- Baby package28 or using the CORE Plus 
tool.46 48 Four studies used key informant interviews (KIIs) 
only,33–35 44 while another study was based on a review of 
documents only.42 Five studies used a combination of KIIs 
and document review27 29–31 36 and one study used KIIs 
and survey.43 Three studies used a combination of KIIs, 
document reviews and physical inventory of resources to 
collect cost data (online supplementary table S4 in file 
1).32 39 45
Eleven studies used some form of ingredient 
approach.27 30 31 33–36 41 44 45 48 This included five studies that 
used methodologies that were variants of the ingredient 
approach—PACCM31 33–35 and the time- driven activity- 
based costing (TDABC).45 Six studies used the expendi-
ture approach32 39 42 43 46 47 and three studies used a mixed 
approach combining both.37 38 40 Two studies did not state 
the costing methods used.28 29 Nineteen studies reported 
only mean cost as a summary measure,27–38 40–48 while the 
other three studies reported mean and median cost of 
service provision.31 33 39 Fifteen studies provided cost data 
that could be disaggregated by service.29–31 33–35 37 38 40–45 48 
Five studies provided cost breakdown by facility or by 
district, but not by service32 36 39 46 47 and two studies did 
not provide any cost breakdown.27 28
Cost of providing maternal health services
Details of the extracted cost of service provision for all 
included studies and the estimated cost following infla-
tion for studies that presented disaggregated costs are 
presented in online supplementary table S5 and table S6 
of file 1, respectively. In the paragraphs below, a summary 
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of the key cost findings of this review are presented per 
maternal health service. For each service, the number 
of studies with disaggregated costs, cost of provision per 
provider type and per facility type as well as major cost 
drivers are presented.
For ANC, five studies provided disaggregated 
cost.29 37 38 41 48 Based on provider type, median cost of 
ANC provided by non- government organisations (NGOs) 
was estimated at US$7.24 across Bangladesh and Haiti, 
US$8.50 for public and missionary provision across Haiti, 
Peru, Rwanda and Uganda and US$31.42 for private 
provision in Rwanda. Comparing cost based on facility 
type, the re- calculated cost of ANC provision ranged 
from US$5.73 in a public health centre (third ANC visit) 
to US$81.01 in a private hospital (first visit). In terms of 
major cost drivers, after excluding capital expenditure, 
personnel, medicines and equipment were the major 
cost drivers for ANC provision in Uganda,29 Bangladesh 
and Rwanda37 41 and Peru,38 respectively (table 1).
For skilled birth attendance, including vaginal and 
caesarean delivery, five studies provided cost data 
for which disaggregation into cost components was 
feasible.29 37 40 42 45 Based on provider type, one study in 
Bangladesh presented cost of NGO provision,37 while the 
other four presented public provision costs.29 40 42 45 Cost 
of providing vaginal delivery at clinics managed by NGO 
(US$35.45) was almost twice the cost of the same service 
provided by public providers in Uganda (US$18.31). 
Based on facility type, at a median cost of US$14.32 
across all public health facility levels, Uganda reported 
the lowest cost for providing vaginal delivery supported 
by a skilled birth attendant (SBA). This was followed by 
US$33.41 and US$74.19 in Bangladesh and Pakistan, 
respectively, excluding overheads and capital expen-
diture. Following similar exclusions, vaginal delivery 
in Brazil was the most expensive at US$278.22. For 
caesarean delivery provided in the public sector, the 
study conducted in Uganda also reported the lowest cost 
at US$72.11 while it was estimated at US$378.94 in Brazil 
excluding overheads and capital expenditure. In terms of 
cost drivers, after excluding capital cost, personnel consti-
tuted the major cost driver for vaginal delivery, ranging 
from 45% in Pakistan at public health centre level to 91% 
in Brazil at hospital level.29 40 Personnel cost was also the 
major driver for caesarean delivery, ranging from 68% to 
85% in the NGO- managed clinic in Bangladesh and the 
public hospital in Brazil, respectively (table 2).37 40
Only one study provided disaggregated costs for PNC. 
This study was conducted in an NGO- managed clinic 
in Bangladesh. The study estimated cost of providing 
PNC at US$5.04, with medicines noted as the major cost 
driver (79%).37 For FP, two studies conducted in Bangla-
desh and Uganda provided total costs disaggregated into 
component costs.29 37 However, only the study, conducted 
in Uganda, specified the type of FP commodity being 
provided.29 In that study, provision of condoms in a health 
centre was the least expensive FP service (US$2.72) while 
the most expensive FP service was the provision of the 
injectable contraceptive, Depo- Provera in a hospital 
(US$5.27).29 As regards cost drivers of service provision, 
personnel cost was higher when commodities such as oral 
pills and Depo- Provera were being provided, while cost 
of supplies were higher than personnel when condoms 
were being provided (table 3).
For PAC, seven studies provided disaggregated cost 
that could be used in this analysis.30 31 33–35 43 44 Based 
on facility type, cost of providing PAC without manage-
ment of complications in a public hospital ranged from 
US$120.66 in Rwanda35 to US$379.40 in Uganda,34 while 
cost of providing simple PAC in a health centre was lower 
with estimates of US$97.09 in Rwanda35 and US$172.09 
in Uganda.34 When PAC presented with complications, 
uterine laceration and shock were the most expen-
sive complications to manage, with costs ranging from 
US$259.52 in Zambia to US$1299.21 in Colombia.30 31 33 
As for cost drivers of PAC, personnel cost for providing 
PAC with complications constituted the lowest propor-
tion of provision cost in Burkina Faso at US$0.77 for 
PAC with incomplete abortion or vaginal laceration 
and US$1.37 for PAC with shock.43 Irrespective of the 
presenting complication, cost of personnel required for 
PAC was highest in Colombia (US$464.33–US$1019.80) 
(table 4).31
One other finding from our review was as it relates to 
the output (number of services) provided for the avail-
able input (total cost). Five studies conducted in Burkina 
Faso, Ghana, Haiti, Peru and Rwanda reported some 
economies of scale in cost of service provision.38 39 41 43 48 
Three of the studies reported this finding in lower cadre 
staffed public facilities such as health centres and 
clinics38 39 41 and one was reported in referral hospital.43 
In Ghana, simply increasing the number of deliveries by 
10% reduced the unit cost per delivery by 18.75% (from 
US$63.23 to US$51.37).39 Similarly, in Peru, Mi Peru 
district had one of the highest total costs of provision but 
it had the lowest mean cost per visit.38
dIsCussIon
This systematic review based on 22 studies covering 17 
individual countries provides the most up- to- date and 
comprehensive overview of cost of maternal health 
service provision in LMICs from year 2000 to today. In 
all, we found that only 16% of all LMICs have at least one 
costing study published. A previous article associated the 
dearth of costing studies in LMICs to the lack of tech-
nical capacity to conduct such studies, and incomplete or 
absent records of activity- linked resource data.49 It might 
also be a case of lack of interest locally on the part of 
policy makers, providers and researchers.
Of the available studies that we were able to retrieve, 
diverse methods were used in collecting and analysing 
cost. Indeed, the impact on final cost estimates that 
these various methods bring are well recognised.50 For 
example, cost estimates will vary depending on if a 
bottom- up or top- down costing approach is taken.50 The 
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real issue though is not the use of different methods, but 
the need for more application of best practices for costing 
in order to improve validity and comparability of results. 
Apart from established best practices including use of 
bottom- up or combined use of both bottom- up and top- 
down costing approaches in a mixed approach, the use 
of US$ or International Dollars in presenting findings 
and incorporation of indirect costs into analysis,25 49 50 
our review showed that there are other methodological 
issues requiring consensus. These include requirement 
for triangulation of data sources for cost analyses, specific 
cost components that should be included, for example, 
should fringe benefits such as health insurance, scholar-
ship for health workers, etc be included in costing? Other 
issues include approach to cost disaggregation, time allo-
cation for health workers and use of median cost as a 
summary measure, as well as approach to amortisation of 
capital projects in cost analyses.
As regards cost of service provision, median cost of 
publicly provided ANC provision in health centres 
across four countries was US$8.50. Cost of ANC was 
slightly cheaper with NGO- led provision while it was 
costlier to provide in hospitals and within the private 
sector. We were able to draw these parallels because all 
studies used the microcosting approach and costing was 
principally based on the 2001 WHO recommendation 
of focused ANC.51 The latest global guidelines however, 
recommend an increase from four visits during preg-
nancy to eight contacts with skilled personnel.52 This 
will ultimately have implications on service cost, as time 
spent in consultation and human resources required 
for ANC contacts will have to increase. As such, cost 
of ANC provision with this new package may be higher 
than initial estimates.
For delivery with skilled birth attendance in public 
health facilities, there was a wide variation for both 
normal vaginal and caesarean delivery with the least 
cost reported in Uganda and the highest in Brazil. 
A previous study suggests that there is a relationship 
between cost per service increments with increasing 
GDP per capita.37 Yet, it is difficult to accept that the 
marked difference in cost is because Brazil is an UMIC 
and others are LMIC/LIC. Looking more closely at the 
break down of cost in Brazil, it becomes apparent that 
the major cost drivers in Brazil relates to personnel. 
While service in Uganda was provided by medical 
doctors, clinical or nursing officers,29 the Brazil study 
costed vaginal delivery provided by obstetricians.40 
Based on this finding, there may be a financial case for 
cost savings as it relates to task- shifting and task- sharing 
of delivery services in LMICs, as has been demonstrated 
for several other global health priorities.53 This finding 
adds to the established evidence on efficiency and 
effectiveness of task- shifting of maternal health inter-
ventions as a policy.54
After adjustments, the range of cost for FP service 
provision estimated in our review was put at US$0.82 
to US$2.72. This tallies with findings from an evidence 
brief by WHO, which estimated the average cost per 
modern contraceptive as US$1.01.55 In our review, FP 
service provision by NGOs was the least costly. This is 
probably because of the significant financial contribu-
tions from international donors which help subsidise 
the cost of FP commodities and the widely lauded effi-
ciency of NGO- managed health services.56 We could 
not ascertain a pattern with cost of PNC provision 
because only one study in our review costed the service 
and provided disaggregated cost, with cost per service 
estimated at US$5.04.37
As complications require more resources, it was 
not surprising to find that PAC with management of 
complications was costlier than PAC alone. The more 
severe the complication, the higher the cost of service 
provision with uterine laceration and shock costing the 
highest. The cost also varied based on type of facility, 
with the service costing more if care is provided in a 
hospital as opposed to health centres. Keeping hospi-
talisation rates to the barest minimum was an approach 
used to reduce cost of PAC provision in South Africa.44 
We noted though that while cost of the actual emer-
gency treatment was reported in all studies, none of the 
studies costed for FP and community empowerment 
through awareness and mobilisation, both of which are 
key components of comprehensive PAC.57
Our review pointed to some economies of scale for 
service provision as reported in Burkina Faso, Ghana, 
Haiti and Rwanda.38 39 41 43 48 This phenomenon 
occurred irrespective of the provider (NGO vs public) 
and the facility level (health centre vs hospital). Indeed, 
a major share of cost of service provision are fixed costs, 
so an increasing output does not necessarily increase 
the unit healthcare provision costs proportionally.58 A 
coordinated approach to ensure maximal utilisation of 
facility- based maternal health services may result in a 
more efficient use of resources for service provision.
Implications for practice and research
Our review highlights some critical methodological 
issues that need to be addressed to develop the prac-
tice of costing maternal health services. We believe 
that propagating consensus around already established 
costing approaches such as the WHO’s Mother- Baby 
Package Costing tool,59 PACCM developed by the Gutt-
macher Institute33 and TDABC, promoted as being valu-
able in LMICs60 will be a good next step in improving 
the quality of costing studies.
Indeed, there is global recognition of the need 
for more transparency and monitoring of financial 
resources required for achieving the SDGs in LMICs.61 
However, from this review, it is clear that the number 
of available costing studies done at high level of meth-
odological rigour that can be used for monitoring 
investments made in maternal health is low in LMICs. 
Certainly, more costing studies of PNC need to be 
conducted to better understand patterns, especially 
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given the need for LMICs to scale up the implementa-
tion of postpartum care.62
strengths and limitations
Strengths of this review are its inclusion of costing 
studies published in both peer- reviewed and grey liter-
ature, inflation of cost to comparable 2019 US Dollar 
equivalents and disaggregation of cost components 
for the various services. Doing this allowed us to for 
the first time be able to compare and contrast costs of 
providing the different maternal health services across 
countries, facility and provider types.
However, some limitations of our review need to be 
acknowledged. It was not possible to make meaningful 
comparisons in all cases. For example, there was only one 
study that costed provision of PNC which also had disag-
gregated cost.37 In addition, we could not fully describe the 
specific package of care provided to women in every study, 
as significant detail on care packages were not typically 
reported in the included studies. However, by including 
only studies published from year 2000, we ensured that 
we were comparing like- for- like recommended services, 
as global guidance regarding care packages were updated 
around this period. Finally, despite our best efforts, there 
were some costing studies not publicly available. For 
example, Blaakman makes reference to costing studies 
published in Kenya, Malawi and Rwanda.47 However, full 
texts of these could not be retrieved. Anecdotal evidence 
also suggests that there are more costing exercises being 
conducted in LMICs by Ministries of Health, many of which 
are not published online.
ConClusIon
While we have been able to move the discussion in 
the field from comparing ‘apples and oranges’ to maybe 
comparing ‘green apples and red apples’, there is still a need 
to build consensus around definitions and methodology 
for costing maternal health services in LMICs. Indeed, 
as evidenced in our review, with rigorous adjustments 
made to cost data, there are some patterns emerging and 
a lot of shared learning on what can be done to increase 
cost savings and improve efficiency and effectiveness 
of service delivery in LMICs. As the global community 
moves forward with planning for and implementing 
service delivery in the SDG era, in addition to increased 
call for transparency, consensus around costing method-
ology is important to improve comparability and increase 
opportunities for learning and evidence- based resource 
allocation across countries.
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